Updates in LN: New Era of Therapies with Dr. Alfred Kim
medcases00
Published on Mar 30, 2022
video embed original source - ottawa nephrology
https://www.youtube.com/channel/UCSSN8hYVMHu6_fAhU3X9JSQ
Dr. Alfred Kim is at Barnes-Jewish Hospital and Assistant Professor of Medicine at Washington University School of Medicine where he also directs the Lupus Clinic and co-directs the Biobanking Core for the Division of Rheumatology. He has an independent research program broadly addressing unmet needs in human systemic lupus erythematosus (SLE), with specific foci in complement (both as biomarkers and its biology in SLE), improving our understanding of the etiologies of social support erosion in our SLE cohort and developing programs to restore it, and using novel noninvasive imaging strategies to detect glomerulonephritis. More recently, Dr. Kim started the COVaRiPAD study, examining the immunogenicity and reactogenicity of SARS-CoV-2 vaccination in systemic autoimmune patients on immunosuppression.
- Your Subscription
medcases00 -
Share Video
Add to
Flag Video
Rate video
Rate video
Up next
Autoplay
Recommended
-
01:31:53
KDIGO Management of Hyperkalemia: New Guidance, Emerging Evidence, and Changing Therapies
10 views 1074 days ago -
45:18
Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
11 views 612 days ago -
51:21
"Updates in Adult Minimal Change Disease" presented by Ruth Campbell
11 views 592 days ago -
01:04:10
Picks of the new European Renal Best Practice Guidelines on Vascular Access
11 views 1072 days ago